KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Current Assets (2016 - 2026)

Zimmer Biomet Holdings has reported Current Assets over the past 18 years, most recently at $5.0 billion for Q1 2026.

  • For Q1 2026, Current Assets fell 11.23% year-over-year to $5.0 billion; the TTM value through Mar 2026 reached $5.0 billion, down 11.23%, while the annual FY2025 figure was $5.1 billion, 9.6% up from the prior year.
  • Current Assets for Q1 2026 was $5.0 billion at Zimmer Biomet Holdings, down from $5.1 billion in the prior quarter.
  • Over five years, Current Assets peaked at $5.8 billion in Q3 2025 and troughed at $4.4 billion in Q3 2023.
  • A 5-year average of $4.8 billion and a median of $4.6 billion in 2024 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: fell 16.69% in 2022 and later rose 20.7% in 2025.
  • Year by year, Current Assets stood at $4.4 billion in 2022, then increased by 4.12% to $4.6 billion in 2023, then rose by 1.35% to $4.7 billion in 2024, then rose by 9.6% to $5.1 billion in 2025, then decreased by 3.07% to $5.0 billion in 2026.
  • Business Quant data shows Current Assets for ZBH at $5.0 billion in Q1 2026, $5.1 billion in Q4 2025, and $5.8 billion in Q3 2025.